TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/16/22 16:14 | 9/15/22 | CRBU | Caribou Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung Barbara G | CA | O | GC | M.d | 74 | 2.69 | 0 | 28 | 8 | 377 | D | ||||||||||||||
12/8/21 18:06 | 12/7/21 | CRBU | Caribou Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung Barbara G | CA | O | GC | P.d | 16 | 2.69 | 0 | 6 | 2 | 349 | D | ||||||||||||||
10/21/21 18:12 | 10/20/21 | CRBU | Caribou Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | McClung Barbara G | CA | O | GC | P.d | 25 | 2.69 | 0 | 9 | 3 | 343 | D | ||||||||||||||
11/16/05 17:01 | 11/16/05 | CYGN | Cygnus Inc /de/ | DE | Electr | LabEq | Measuring & Controlling Devic | McClung Barbara G | CA | O | GC, Corp | M.d | 18 | 0.1225 | 0 | 150 | New | 150 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |